Rebecca J. Howard

Rebecca J. Howard

Auto-generated profile, based on publicly available information

Rebecca J. Howard

Science for Life Laboratory, Department of Biochemistry and Biophysics, Stockholm University, Solna, Sweden

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in Nature
Verified
Journal Article
Closed access
PDF file
JKJeong Joo Kim
Jeong Joo Kim
AGAnant Gharpure
Anant Gharpure
JTJinfeng Teng
Jinfeng Teng
YZYuxuan Zhuang
Yuxuan Zhuang
RHRebecca J. Howard
Rebecca J. Howard
RHRyan E. Hibbs
Ryan E. Hibbs

1 December 2003 in Molecular Cell
Verified
Journal Article
Closed access
HWHelen Walden
Helen Walden
MPMichael S Podgorski
Michael S Podgorski
DHDanny T Huang
Danny T Huang
DMDavid W Miller
David W Miller
RHRebecca J Howard
Rebecca J Howard
BSBrenda A Schulman
Brenda A Schulman

1 March 2007 in Neuron
Verified
Journal Article
Closed access
RHRebecca J. Howard
Rebecca J. Howard
KCKimberly A. Clark
Kimberly A. Clark
JHJames M. Holton
James M. Holton
DMDaniel Minor
Daniel Minor

16 April 2013 in Nature Communications
Verified
Journal Article
Open access
PDF file
LSLudovic Sauguet
Ludovic Sauguet
RHRebecca J. Howard
Rebecca J. Howard
LMLaurie Malherbe
Laurie Malherbe
ULUi S. Lee
Ui S. Lee
PCPierre-Jean Corringer
Pierre-Jean Corringer
MDMarc Delarue
Marc Delarue
Ethanol alters nerve signalling by interacting with proteins in the central nervous system, particularly pentameric ligand-gated ion channels. A recent series of mutagenesis experiments on Gloeobacter violaceus ligand-gated ion channel, a prokaryotic member of this family, identified a single-site variant that is potentiated by pharmacologically relevant concentrations of ethanol. Here we determine crystal structures of the ethanol-sensitized variant in the absence and presence of ethanol and related modulators, which bind in a transmembrane cavity between channel subunits and may stabilize the open form of the channel. Structural and mutagenesis studies defined overlapping mechanisms of potentiation by alcohols and anaesthetics via the inter-subunit cavity. Furthermore, homology modelling show this cavity to be conserved in human ethanol-sensitive glycine and GABA(A) receptors, and to involve residues previously shown to influence alcohol and anaesthetic action on these proteins. These results suggest a common structural basis for ethanol potentiation of an important class of targets for neurological actions of ethanol.

5 July 2011 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
RHRebecca J. Howard
Rebecca J. Howard
SMSamuel Murail
Samuel Murail
KOKathryn E. Ondricek
Kathryn E. Ondricek
PCPierre-Jean Corringer
Pierre-Jean Corringer
ELErik Lindahl
Erik Lindahl
RHR. Adron Harris
R. Adron Harris
Despite its long history of use and abuse in human culture, the molecular basis for alcohol action in the brain is poorly understood. The recent determination of the atomic-scale structure of GLIC, a prokaryotic member of the pentameric ligand-gated ion channel (pLGIC) family, provides a unique opportunity to characterize the structural basis for modulation of these channels, many of which are alcohol targets in brain. We observed that GLIC recapitulates bimodal modulation byn-alcohols, similar to some eukaryotic pLGICs: methanol and ethanol weakly potentiated proton-activated currents in GLIC, whereasn-alcohols larger than ethanol inhibited them. Mapping of residues important to alcohol modulation of ionotropic receptors for glycine, γ-aminobutyric acid, and acetylcholine onto GLIC revealed their proximity to transmembrane cavities that may accommodate one or more alcohol molecules. Site-directed mutations in the pore-lining M2 helix allowed the identification of four residues that influence alcohol potentiation, with the direction of their effects reflecting α-helical structure. At one of the potentiation-enhancing residues, decreased side chain volume converted GLIC into a highly ethanol-sensitive channel, comparable to its eukaryotic relatives. Covalent labeling of M2 positions with an alcohol analog, a methanethiosulfonate reagent, further implicated residues at the extracellular end of the helix in alcohol binding. Molecular dynamics simulations elucidated the structural consequences of a potentiation-enhancing mutation and suggested a structural mechanism for alcohol potentiation via interaction with a transmembrane cavity previously termed the “linking tunnel.” These results provide a unique structural model for independent potentiating and inhibitory interactions ofn-alcohols with a pLGIC family member.

6 August 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
SZShaotong Zhu
Shaotong Zhu
ASAkshay Sridhar
Akshay Sridhar
JTJinfeng Teng
Jinfeng Teng
RHRebecca J. Howard
Rebecca J. Howard
ELErik Lindahl
Erik Lindahl
RHRyan E. Hibbs
Ryan E. Hibbs
γ-Aminobutyric acid type A (GABAA) receptors are pentameric ligand-gated ion channels abundant in the central nervous system and are prolific drug targets for treating anxiety, sleep disorders and epilepsy. Diverse small molecules exert a spectrum of effects on γ-aminobutyric acid type A (GABAA) receptors by acting at the classical benzodiazepine site. They can potentiate the response to GABA, attenuate channel activity, or counteract modulation by other ligands. Structural mechanisms underlying the actions of these drugs are not fully understood. Here we present two high-resolution structures of GABAA receptors in complex with zolpidem, a positive allosteric modulator and heavily prescribed hypnotic, and DMCM, a negative allosteric modulator with convulsant and anxiogenic properties. These two drugs share the extracellular benzodiazepine site at the α/γ subunit interface and two transmembrane sites at β/α interfaces. Structural analyses reveal a basis for the subtype selectivity of zolpidem that underlies its clinical success. Molecular dynamics simulations provide insight into how DMCM switches from a negative to a positive modulator as a function of binding site occupancy. Together, these findings expand our understanding of how GABAA receptor allosteric modulators acting through a common site can have diverging activities.